Role of IDO activation in anti-microbial defense in human native astrocytes

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 15-26

  Oberdörfer, Claudia ^b   Adams, Ortwin ^b   MacKenzie, Colin R ^b   De Groot, Corline J A ^b   Däubener, Walter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; BACTERIAL GROWTH; CELL ACTIVATION; CELL CULTURE; CELL STIMULATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE; TOXOPLASMA GONDII; VIROGENESIS; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); POSIBACTERIA; PROTOZOA; SIMPLEXVIRUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B'; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 1042302741     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_2     Document Type: Conference Paper

References (29)

1. W. Fierz, B. Endler, K. Reske, H. Wekerle, A. Fontana, Astrocytes as antigen-presenting cells, J. Immunol. 134, 3785-3793 (1985).
2. S.C. Lee, W. Liu, D.W. Dickson, C.F. Brosnan, J.W. Berman, Cytokine production by human fetal microglia and astrocytes, J. Immunol. 159, 2659-2667 (1993).
3. P. Van der Voom, J. Tekstra, R.H.J. Beelen, Tensen C.P., P. van der Valk, C.J.A. de Groot, Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions, Am. J. Pathol. 154, 45-51 (1999).
4. F. Aloisi, G. Borsellino, P. Samoggia, U. Testa, C. Cheiucci, G. Russo, C. Peschle, G. Levi, Astrocyte cultures from human embryonic brain: characterisation and modulation of surface molecules by inflammatory cytokines, J. Neurosci. Res. 32, 494-506 (1992).
5. F.Y. Liew and F.E.G. Cox, Nonspecific defence mechanism: the role of nitric oxide, Immunol. Tod. 12:17-21 (1991).
6. S.C. Lee, D.W. Dickson, C.F. Brosnan and A. Casadevall, Human astrocytes inhibit cryptopcoccus neoformans growth by a nitric oxide-mediated mechanism, J. Exp. Med. 180, 365-369 (1994).
7. P.K. Peterson, G. Gekker, S. Hu, C.C. Chao, Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism, J. Infect. Dis. 171, 516-518 (1995).
8. E.R. Pfefferkorn, Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. 81, 908-912 (1984).
9. W. Däubener, K. Pilz, S. Seghrouchni-Zennati, T. Bilzer, H.G. Fischer and U. Hadding, Induction of toxoplasmostasis in a human glioblastoma by interferon-γ, J. Neuroimmunol. 43, 31-38 (1993).
10. C.N. Nagineni, K. Pardhasaradhi, Martins, B. Detrick and J.J. Hooks, Mechanism of interferon-induced inhibition of Toxoplasma gondii replication in human retinal epithelial cells, Infect. Immun. 64, 4188-4196 (1996).
11. G.I. Byrne, L.K. Lehmann and G.J. Landry, Induction of tryptophan catabolism is the mechanism for gamma interferon mediated inhibition of intracellular Chlamydia psitacci replication in T24 cells, Infect. Immun. 53, 347-351 (1986).
12. C.R. MacKenzie, U. Hadding and W. Däubener, Interferon-g-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci, J. Infect. Dis. 178, 875-878 (1998).
13. Y. Ozaki, M.P. Edelstein and D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon-g, Proc. Natl. Acad. Sci. USA 81, 908-912 (1988).
14. T.W. Stone, Neuropharmacology of quinolonic and kynurenic acids, Pharmacol. Rev. 45, 309-379 (1993).
15. S.C. Lee, D.W. Dickson, W. Liu and C.F. Brosnan, Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β; and interferon-γ, J. Neuroimmunol. 46, 19-24 (1993).
16. W. Däubener, N. Wanagat, K. Pilz, S. Seghrouchni, H.G. Fischer and U. Hadding, A new, simple, bioassay for human IFN-γ, J. Immunol. Meth. 168, 39-47 (1994).
17. C.J.A. de Groot, C.H. Langeveld, C.A.M. Jongenelen, L. Montagne, P. van der Valk and C.D. Dijkstrat, Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions, J. Neurosci. Res. 49, 342-354 (1997).
18. W. Däubener, C. Remscheid, S. Nockemann, K. Pilz, S. Seghrouchni, C.R. MacKenzie and U. Hadding, Anti-parasitic effector-mechanisms in human brain tumor cells: Role of IFN-γ and tumor nekrosis factor-α, Eur. J. Immunol. 26, 487-492 (1996).
19. C.R. MacKenzie, C.B. Willberg and W. Däubener, Inhibition of group B streptococcal growth by IFN-γ activated human glioblastoma cells, J. Neuroimmunol. 89, 191-197 (1998).
20. S.R. Thomas, D. Mohr and R. Stocker, Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-g primed mononuclear phagocytes, J. Biol. Chem. 269, 14457-14464 (1994).
21. R. Fagard, H. van Tan, C. Creuzet and H. Pelloux, Differential development of toxoplasma gondii in neural cells, Parasitol. Tod. 15, 504-507 (1999).
22. C.C. Chao, W.R. Anderson, S. Hu, G. Gekker, A. Martella and P. Peterson, Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism, Clin. Immunol. Immunopathol. 67, 178-183 (1993).
23. C.C. Chao, G. Gekker, S. Hu and P. Peterson, Human microglia cell defense against toxoplasma gondii, J. Immunol. 152, 1246-1252 (1994).
24. M.P. Heyes, C.L. Achim, C.A. Wiley, E.O. Major, K. Saito and S.P., Markey, Human microglia convert L-tryptophan into the neurotoxin quinolonic acid, Biochem. J. 320, 595-597 (1996).
25. B. Bodaghi, O. Goureau, D. Zipeto, L. Laurent, J.L. Virelizier and S. Michelson, Role of IFN-γ-induced indeoleamine 2,3-Dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells, J. Immunol. 162, 957-964 (1999).
26. S.K. Halonen, F.C. Chiu and L.M. Weiss, Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes, Infect. Immun. 66, 4989-4993 (1998).
27. W. Däubener, C. Hucke, K. Seidel, U. Hadding and C.R. MacKenzie, Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells, Infect. Immun. 67, 5615-5620 (1999).
28. D. Alberati-Giani, P. Malherbe, R. Castagnoli, C. Köhler, S. Denis-Donini and A.M. Cesura, Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IIFN-γactivated murine macrophages and microglial cells, J. Immunol. 159, 419-426 (1997).
29. W. Bohne, J. Heesemann and U. Gross, Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion, Infect. Immun. 62, 1761-1767 (1994).